AAIC 2025 Abstract
The Underlying Pathophysiology of Resilience to Alzheimer's Disease Pathology: Preliminary Results of a CSF Proteomics Study
By Jolien van der Velden, Aurore Delvenne, Stephanie J. B. Vos, Show 7 more authorsEMIF-AD MBD study group
Study in peopleMechanisms
Abstract
Background: Up to 25% of individuals with AD pathology (amyloid‐β deposition and tau neurofibrillary tangles) remain cognitively healthy throughout life, showing resilience to AD. The neurobiological mechanisms behind this resilience remain largely unknown, yet understanding this could inform preventive interventions against AD.
